Analysis of HLA haplotypes in autoimmune hepatitis type 1:: Identifying the major susceptibility locus

被引:51
作者
Goldberg, AC
Bittencourt, PL
Mougin, B
Cançado, ELR
Porta, G
Carrilho, F
Kalil, J
机构
[1] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Inst Heart, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med, Childrens Inst, Liver Unit, Sao Paulo, Brazil
[4] Biomerieux, Dept Sondes Nucl, Lyon, France
[5] Howard Hughes Med Inst, Chevy Chase, MD USA
基金
巴西圣保罗研究基金会;
关键词
HLA genes; autoimmune hepatitis; genetic susceptibility; peptide presentation;
D O I
10.1016/S0198-8859(00)00234-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to autoimmune hepatitis type I (AIH-1) has been associated with HLA-DR3, DR52, acid DR4 antigens in Caucasian and Oriental patients. However, in Brazil, disease susceptibility is primarily linked to DR13 and DR52. In this highly admired population, we find different DR13-associated haplotypes, presenting a unique opportunity to discriminate relevant genes within a tightly linked genomic region. To identify the primary susceptibility locus, we sequenced DR13 alleles of 39 patients with AIH-1 and 22 controls. Patients were almost exclusively DRB1*1301, bur half of controls typed DRB1*1302. HLA-DQ haplotypes were varied. Oligotyping of DRD3 locus of all patients and also within the HLA-DR13 positive group showed an allele distribution comparable to controls, confirming that the stronger association lies in the DRB1 locus. On the other hand, if DRB1*1301 is the major susceptibility factor in our sample, the only amino acid different from DRB1*1302 in position 86, corresponding to pocket 1 in the peptide-presenting groove, may be important. We Propose that peptide presentation leading to pathogenesis of AIH-1 may ie quite stringent, but will also be affected by other strong genetic or environmental susceptibility factors, which would explain the various HLA molecules associated to the disease in the different populations. (C) American Society for Histocompatibility and Immunogenetics, 2001. Published by Elsevier Science Inc.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 23 条
[1]  
BIGNON JD, 1995, HLA GENETIC DIVERSIT
[2]  
Bittencourt PL, 1999, AM J GASTROENTEROL, V94, P1906
[3]   Nomenclature for factors of the HLA system, 1998 [J].
Bodmer, JG ;
Marsh, SGE ;
Albert, ED ;
Bodmer, WF ;
Bontrop, RE ;
Dupont, B ;
Erlich, HA ;
Hansen, JA ;
Mach, B ;
Mayr, WR ;
Parham, P ;
Petersdorf, EW ;
Sasazuki, T ;
Schreuder, GMT ;
Strominger, JL ;
Svejgaard, A ;
Terasaki, PI .
TISSUE ANTIGENS, 1999, 53 (04) :407-446
[4]  
Cancado ELR, 1996, HEPATOLOGY, V23, P1098
[5]  
CROS P, 1992, LANCET, V340, P873
[6]  
Czaja AJ, 1997, HEPATOLOGY, V25, P317
[7]   AUTOIMMUNE HEPATITIS - EVOLVING CONCEPTS AND TREATMENT STRATEGIES [J].
CZAJA, AJ .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (02) :435-456
[8]   NATURALLY PROCESSED PEPTIDES FROM 2 DISEASE-RESISTANCE-ASSOCIATED HLA-DR13 ALLELES SHOW RELATED SEQUENCE MOTIFS AND THE EFFECTS OF THE DIMORPHISM AT POSITION-86 OF THE HLA-DR-BETA CHAIN [J].
DAVENPORT, MP ;
QUINN, CL ;
CHICZ, RM ;
GREEN, BN ;
WILLIS, AC ;
LANE, WS ;
BELL, JI ;
HILL, AVS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) :6567-6571
[9]  
DIELPOLDER HM, 1998, CLIN EXP IMMUNOL, V113, P244
[10]   ALLELIC SEQUENCE VARIATION IN THE HLA CLASS-II GENES AND PROTEINS IN PATIENTS WITH AUTOIMMUNE HEPATITIS [J].
DOHERTY, DG ;
DONALDSON, PT ;
UNDERHILL, JA ;
FARRANT, JM ;
DUTHIE, A ;
MIELIVERGANI, G ;
MCFARLANE, IG ;
JOHNSON, PJ ;
MOWAT, AP ;
WILLIAMS, R ;
EDDLESTON, ALWF .
HEPATOLOGY, 1994, 19 (03) :609-615